Log In
Print
BCIQ
Print
Print this Print this
 

BEMA Buprenorphine (EN3409) (formerly BEMA LA)

  Manage Alerts
Collapse Summary General Information
Company BioDelivery Sciences International Inc.
DescriptionBuprenorphine formulated with the BEMA transmucosal delivery system
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat moderate to severe chronic pain; Treat pain
Regulatory Designation

Partner

Endo International plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today